Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03884101 |
|---|---|
| Brief Title: | Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) (LEAP-001) |
| First Submitted : | March 19, 2019 |
| First Submitted that Met QC Criteria : | March 19, 2019 |
| First Posted : | March 21, 2019 |
| Last Update Submitted that Met QC Criteria : | March 24, 2021 |
| Last Update Posted : | March 26, 2021 |